Skip to main content
. 2021 Feb 2;13(3):578. doi: 10.3390/cancers13030578

Table 1.

Patient data (n = 15).

Patient Age (Years) Serum PSA (ng/mL) pT-Stage Gleason GG pN+ Adj. ADT
1 69 31.00 pT3a 3 + 4 2 yes yes
2 72 32.00 pT3b 4 + 3 3 no yes
3 65 83.70 pT4 3 + 4 2 no yes
4 73 50.10 pT4 4 + 5 5 no yes
5 62 23.40 pT3b 3 + 3 1 no yes
6 72 23.92 pT3a 3 + 4 2 no yes
7 63 22.61 pT4 4 + 3 3 yes yes
8 73 32.80 pT3b 4 + 4 4 yes yes
9 77 58.00 pT3b 3 + 4 2 yes no
10 76 33.50 pT3b 4 + 3 3 no yes
11 63 25.41 pT3b 3 + 4 2 yes yes
12 70 48.35 pT3a 3 + 3 1 yes yes
13 67 153.00 pT3a 3 + 4 2 yes yes
14 56 42.70 pT3a 3 + 4 2 no yes
15 77 110.00 pT3b 5 + 4 5 no yes

Abbreviations: PSA, prostate-specific antigen; pT stage, pathologic stage after prostatectomy; GG, Grade group; pN, pathological proven lymph node metastasis; Adj. ADT, Adjuvant androgen deprivation therapy.